Actinogen Medical Limited (ATGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0250
+0.0010 (4.17%)
Sep 12, 2025, 12:39 PM EDT
Actinogen Medical Revenue
In the fiscal year ending June 30, 2025, Actinogen Medical had annual revenue of 5.49M AUD, down -44.73%. Actinogen Medical had revenue of 5.49M in the half year ending June 30, 2025, with 41.34% growth.
Revenue
5.49M AUD
Revenue Growth
-44.73%
P/S Ratio
15.81
Revenue / Employee
914.93K AUD
Employees
6
Market Cap
56.89M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 5.49M | -4.44M | -44.73% |
Jun 30, 2024 | 9.93M | 5.04M | 103.18% |
Jun 30, 2023 | 4.89M | 1.25M | 34.28% |
Jun 30, 2022 | 3.64M | 1.66M | 83.47% |
Jun 30, 2021 | 1.98M | -1.53M | -43.58% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
Actinogen Medical News
- 4 months ago - Actinogen provides pivotal Alzheimer's trial enrolment update and other business news - Benzinga